Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. DRI
9. NVDA
10. FDXF

Go back to Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
(NASDAQ: CMND) Delayed: 2.38 -0.11 (4.42%)
Previous Close $2.49    52 Week High $ 
Open $2.44    52 Week Low $ 
Day High $2.50    P/E N/A 
Day Low $2.36    EPS $ 
Volume 39,282